Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
Sales | 21 | 27 | 10 | 0 | 0 |
Cost of Goods | 0 | N/A | 10 | 0 | 0 |
Gross Profit | 20 | 27 | 0 | 0 | 0 |
Operating Expenses | 6,190 | 0 | 2,630 | 2,710 | 2,840 |
Operating Income | -6,169 | 27 | -2,620 | -2,710 | -2,840 |
Other Income | 279 | 0 | 150 | 190 | 230 |
Pre-tax Income | -5,890 | 27 | -2,470 | -2,520 | -2,610 |
Net Income Continuous | -5,948 | -3,327 | -2,471 | -2,532 | -2,633 |
Net Income | $-5,948 | $-3,327 | $-2,471 | $-2,532 | $-2,633 |
EPS Basic Total Ops | -216.19 | -152.98 | -108.10 | -108.10 | -108.10 |
EPS Basic Continuous Ops | -187.63 | -152.61 | -92.55 | -94.83 | -98.61 |
EPS Diluted Total Ops | -216.19 | -152.98 | -108.10 | -108.10 | -108.10 |
EPS Diluted Continuous Ops | -187.63 | -152.61 | -92.55 | -94.83 | -98.61 |
EBITDA(a) | $-7,269 | $1,087 | $-2,200 | $-2,670 | $-4,910 |